A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/16 (2006.01) A61K 39/395 (2006.01) C07K 14/00 (2006.01) C07K 16/00 (2006.01)
Patent
CA 2626859
The present invention provides methods for treating adverse events related to immunotherapy. More specifically, the present invention provides methods for treating the enterocolitis associated with anti-CTLA-4 antibody immunotherapy.
La présente invention concerne des méthodes destinées à traiter les effets secondaires associés à une immunothérapie. Plus particulièrement, la présente invention concerne des méthodes destinées à traiter l'entérocolite associée à une immunothérapie par anticorps anti-CTLA-4.
Fischkoff Steven
Lowy Israel
Yang James Chung-Yin
Yellin Michael
Medarex Inc.
Smart & Biggar
The Government Of The United States Of America As Represented By
LandOfFree
Tnf-alpha blocker treatment for enterocolitis associated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tnf-alpha blocker treatment for enterocolitis associated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tnf-alpha blocker treatment for enterocolitis associated... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1501846